Stephen Palmer

Professor, Deputy Director of TEEHTA, Centre for Health Economics, York University

Stephen Palmer

Stephen Palmer is a Professor and Deputy Director of TEEHTA. He has worked in economic evaluation for over 15 years in areas including pharmaceuticals, cardiology, cancer, mental health, diagnostic and screening programmes and policy. He has extensive experience of health economic evaluation, regulatory and reimbursement processes.

His principal areas of expertise relate to the methodology and application of decision-analytic modelling and Bayesian approaches to Health Technology Assessment. He has worked closely with policy makers and currently leads the programme of work at CHE for the National Institute for Health and Clinical Excellence (NICE) and he is also a member of the NICE Decision Support Unit.

He has advised policy makers internationally including in the USand Canada. He is currently a member of the NICE Technology Appraisal Committee and the NIHR Research for Patient Benefit Programme.

Keynote Speakers

A. John Iafrate Dr. Iafrate is a Professor of Pathology at Harvard Medical School and is Director of the Center for Integrated Diagnostics (CID), a clinical laboratory for molecular diagnostics and newly appointed Vice Chair of Academic Affairs at the Massachusetts General Hospital (MGH).

Stephen Palmer Stephen Palmer is a Professor and Deputy Director of TEEHTA. He has worked in economic evaluation for over 15 years in areas including pharmaceuticals, cardiology, cancer, mental health, diagnostic and screening programmes and policy. He has extensive experience of health economic evaluation, regulatory and reimbursement processes.

Luca Sangiorgi He is Head of Department of Medical Genetics and Coordinator of Rare Disease Centre at Rizzoli Orthopaedic Institute, Bologna, and Contract professor of Clinical Genetics of Bologna University.